The effect of low-dose interleukin-2-based immunotherapy on salivary function and composition in patients with metastatic renal cell carcinoma
To access this article, please choose from the options below
PII: S0003-9969(01)00008-5
© 2001 Elsevier Science Ltd. All rights reserved.
